Home > Our Company
About Spectrum Pharmaceuticals
Spectrum Pharmaceuticals is a commercial-stage biotechnology company with fully integrated commercial and drug development operations, and a focus in oncology and hematology.

Our primary strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. In addition to building an efficient in-house clinical development organization with regulatory and data management capabilities, Spectrum has established a commercial infrastructure for its marketed products. We have three oncology products on the market, two for different types of non-Hodgkin's lymphoma and one for advanced metastatic colorectal cancer, as well as two drugs in late stage development: apaziquone and belinostat, along with a diverse pipeline. We also leverage the expertise of our worldwide partners to assist in the execution of our strategy.
Our passion to identify, develop and deliver important options for people suffering from cancer is behind every action we take. At Spectrum, we are committed to excellence and strive to make a difference in the lives of patients every day.
The Key is our People
Collectively, the members of our team have relevant experience in both the development and marketing of oncology drugs and the growth of profitable business ventures.
|
 |
Corporate Presentation
Click here or on the image below to view our current Corporate Presentation.
Careers at Spectrum
Visit our careers page to learn about new job opportunities and how to become a part of the Spectrum team.
Spectrum Highlights
- 2009: Voted One of Best Companies to Work for
- OC Register
- 2005: Voted One of Best Companies to Work for
- OC Metro Magazine
- Ranked one of the fastest growing companies in North America
- Deloitte's 2010 Technology Fast 500
|
Our Goal is to Bring Quality Drugs to Patients
Spectrum Pharmaceuticals actively seeks to leverage its extensive contacts in the pharmaceutical and scientific communities to identify potentially important drug candidates that require further clinical development.
Once we identify these candidates, we rapidly assess preclinical and clinical data, and the commercialization potential of candidates. Then through both in-licensing and co-development partnerships, we provide the expertise and neccesary funding to bring the most promising products through the complex development process to market.
In order to maximize the commercial potential of our current and future drugs, Spectrum has assembled a distinguished Commercial Team that was recruited from the top sales performers in the oncology specialty arena, and who are dedicated to bringing important, quality treatments to cancer patients.

Spectrum's Code of Conduct
At Spectrum:
- We will use all lawful and ethical means
possible to bring our therapy options to the
right patients, in the right way.
- We will be personally responsible to understand
and adhere to the letter and spirit of all laws and
company polices that pertain to our daily
business.
- We will partner only with healthcare
professionals, suppliers, and other business
partners who share our commitment to
understand and uphold the laws and
regulations that apply to our operations.
- We will respect and protect the dignity and
privacy of patients, healthcare professionals and
their staff, business partners, competitors, and
our fellow employees.
- We will promptly and cooperatively report
without fear of retaliation any behavior contrary
to these principles to management, the
compliance officer, or the compliance and
whistleblower hotline.
You may contact Spectrum's Compliance Officer at any time at: compliance at sppirx.com
Back to top |